A coronary artery calcium score measures calcified plaque in the heart's arteries with a quick, low-dose CT scan, and it is one of the most useful tools for refining heart disease risk when the decision about prevention is uncertain. It works best alongside a validated risk calculator, a full lipid profile including ApoB and lipoprotein(a), and blood pressure and metabolic markers. No single number tells the whole story, but together they allow far more personalized decisions than cholesterol alone.
Step One: Estimating Baseline Risk
Cardiovascular prevention usually begins with a population-based risk equation.
- Pooled Cohort Equations (PCE). Used in the 2018 AHA/ACC cholesterol guideline to estimate 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in adults 40 to 79.
- PREVENT equations. Published by the American Heart Association in 2023–2024, these estimate 10- and 30-year risk of cardiovascular disease in adults 30 to 79, incorporate kidney function, and do not use race. They can optionally include HbA1c and urine albumin. Their risk estimates tend to be lower than the older equations for many people.
Calculators are a starting point. They are built on averages and can underestimate or overestimate risk for a specific individual — which is exactly where additional testing helps.
Step Two: Risk Enhancers
The 2018 cholesterol guideline lists "risk-enhancing factors" that favor more aggressive prevention when baseline risk is borderline or intermediate. Among them:
- Family history of premature ASCVD (a male first-degree relative before 55, female before 65).
- Persistently elevated LDL cholesterol, triglycerides or ApoB.
- Elevated lipoprotein(a).
- Elevated hs-CRP.
- Metabolic syndrome or chronic kidney disease.
- Chronic inflammatory conditions such as rheumatoid arthritis, psoriasis or HIV.
- History of preeclampsia or premature menopause.
- South Asian ancestry — relevant to many of the patients I see.
Step Three: The Coronary Artery Calcium Score
What it measures
Calcium in the coronary arteries is a marker of established atherosclerotic plaque. The scan, reported as an Agatston score, takes minutes, requires no contrast and involves a low radiation dose. Results are often also reported as a percentile compared with people of the same age, sex and ethnicity.
How it changes decisions
For adults 40 to 75 at intermediate risk, when the statin decision is uncertain, the 2018 guideline uses the coronary artery calcium score this way:
- Score of 0: reasonable to defer statin therapy and reassess in 5 to 10 years — unless the person smokes, has diabetes or has a family history of premature heart disease.
- Score of 1 to 99: favors starting a statin, particularly in those 55 and older.
- Score of 100 or higher, or at or above the 75th percentile: statin therapy is indicated.
The power of a zero score is in reassurance; the power of a high score is in motivating treatment that a person might otherwise postpone.
What it does not tell you
- Soft plaque. Non-calcified plaque, more common in younger people and smokers, is invisible on a calcium scan.
- Symptoms. A calcium score is not a test for chest pain. Symptoms need a different evaluation.
- Progression on its own. Statins can increase plaque calcification as plaque stabilizes, so a rising score on treatment does not necessarily mean failure.
Beyond the Calcium Score
Coronary CT angiography
CT angiography uses contrast to show both calcified and non-calcified plaque and the degree of narrowing. It is typically reserved for evaluating symptoms or when a specific clinical question justifies the contrast and higher radiation exposure.
Blood pressure and metabolic health
Blood pressure, glucose regulation, kidney function and visceral fat are major drivers of risk. They often matter as much as cholesterol. See Blood Pressure Optimization Beyond Standard Targets and Metabolic Health Markers Every Adult Should Track.
Fitness
Low cardiorespiratory fitness is a strong, independent predictor of cardiovascular events. It is modifiable and should be part of every prevention plan.
How I Use Risk Scoring at Laeeq M.D.
In my practice, cardiovascular risk assessment is a sequence, not a single test:
- History — personal, family and ancestry, smoking, pregnancy history, inflammatory diseases.
- Labs — lipid panel with ApoB, Lp(a) once, HbA1c, kidney function, hs-CRP.
- Risk calculation — using validated equations, with transparency about their limits.
- Coronary artery calcium score when results are borderline or intermediate and the decision would change.
- A shared plan — lifestyle foundation, and when indicated, FDA-approved therapies such as statins or other lipid-lowering medications.
Prevention is a long game. For a broader perspective, read Chronic Disease Prevention: The 10-Year Horizon.
The goal of risk scoring is not to find a reason to medicate or a reason to avoid medication. It is to match the intensity of prevention to the individual's actual risk.
Sources
- 2018 AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol: Ten Points to Remember — American College of Cardiology, 2018. https://acc.org/latest-in-cardiology/ten-points-to-remember/2018/11/09/14/28/2018-guideline-on-management-of-blood-cholesterol
- Top Things to Know: 2018 Guideline on the Management of Blood Cholesterol — American Heart Association Professional. https://professional.heart.org/en/science-news/2018-guideline-on-the-management-of-blood-cholesterol/top-things-to-know
- Development and Validation of AHA's PREVENT Equations (Circulation journal scan) — American College of Cardiology, 2024. https://acc.org/Latest-in-Cardiology/Journal-Scans/2024/02/12/16/45/development-and-validation
Book a Consultation
If you want to understand your true cardiovascular risk — and whether a coronary calcium scan or other testing makes sense — Dr. Laeeq offers a 60-minute evaluation, virtually or in person in Reston, VA. Book a consultation to review your history and labs.
This article is for educational purposes and is not medical advice. Discuss any treatment with a licensed physician who knows your history.
Frequently asked questions

Written by Dr. Laeeq Ahmed Butt, M.D., MBA
Board-certified internist practicing peptide and longevity medicine in Reston, VA, with virtual care in seven states. About Dr. Laeeq